CN118891358A - 鸡滑液囊支原体活疫苗 - Google Patents

鸡滑液囊支原体活疫苗 Download PDF

Info

Publication number
CN118891358A
CN118891358A CN202380027812.2A CN202380027812A CN118891358A CN 118891358 A CN118891358 A CN 118891358A CN 202380027812 A CN202380027812 A CN 202380027812A CN 118891358 A CN118891358 A CN 118891358A
Authority
CN
China
Prior art keywords
birds
vaccine
mycoplasma
composition
challenged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380027812.2A
Other languages
English (en)
Chinese (zh)
Inventor
N·M·弗格森-诺埃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc
Original Assignee
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc filed Critical University of Georgia Research Foundation Inc
Publication of CN118891358A publication Critical patent/CN118891358A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202380027812.2A 2022-03-14 2023-03-13 鸡滑液囊支原体活疫苗 Pending CN118891358A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263319532P 2022-03-14 2022-03-14
US63/319532 2022-03-14
PCT/US2023/015103 WO2023177620A1 (en) 2022-03-14 2023-03-13 Live mycoplasma synoviae vaccine

Publications (1)

Publication Number Publication Date
CN118891358A true CN118891358A (zh) 2024-11-01

Family

ID=88024180

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380027812.2A Pending CN118891358A (zh) 2022-03-14 2023-03-13 鸡滑液囊支原体活疫苗

Country Status (8)

Country Link
US (1) US20250186512A1 (https=)
EP (1) EP4493202A1 (https=)
JP (1) JP2025509627A (https=)
CN (1) CN118891358A (https=)
AR (1) AR128777A1 (https=)
AU (1) AU2023235062A1 (https=)
MX (1) MX2024011062A (https=)
WO (1) WO2023177620A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
EP3391903B1 (en) * 2017-04-21 2022-02-23 The Pirbright Institute Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens
CN112779193B (zh) * 2021-02-24 2022-09-27 福建省农业科学院畜牧兽医研究所 一株滑液囊支原体强毒株及其应用

Also Published As

Publication number Publication date
MX2024011062A (es) 2024-09-23
US20250186512A1 (en) 2025-06-12
WO2023177620A9 (en) 2024-05-10
JP2025509627A (ja) 2025-04-11
EP4493202A1 (en) 2025-01-22
AU2023235062A1 (en) 2024-09-19
WO2023177620A1 (en) 2023-09-21
AR128777A1 (es) 2024-06-12

Similar Documents

Publication Publication Date Title
US8679504B2 (en) Poultry viral materials and methods related thereto
US20080254063A1 (en) Vaccines and Methods to Treat Canine influenza
CN119816588A (zh) 鸡毒支原体活疫苗
CN114302956B (zh) 具有扩展的细胞培养嗜性和组织嗜性的减毒的ibv
US11814653B2 (en) Attenuated isolate of infectious bronchitis virus strain DMV1639
CN102292432B (zh) 鸡败血支原体制剂
US20160032253A1 (en) Attenuation of infectious bronchitis virus variant ga-13
US7217420B2 (en) Mycoplasma gallisepticum formulation
CN114828883A (zh) 减毒禽类呼肠孤病毒株94826 c140和96139 c140
US20250186512A1 (en) Live mycoplasma synoviae vaccine
Tarpey et al. Onset of immunity following in ovo delivery of avian metapneumovirus vaccines
Reed et al. Quail bronchitis
RU2844767C1 (ru) Аттенуированный изолят штамма dmv1639 вируса инфекционного бронхита
JONES 15iv Infectious Laryngotracheitis
Velayudhan et al. Development of a vaccine-challenge model for avian metapneumovirus subtype C in turkeys
Ferguson The evaluation of a live Mycoplasma gallisepticum vaccine candidate and DNA sequence analysis in the molecular epidemiology of Mycoplasma gallisepticum
Escobar-Alfonso et al. AVIAN METAPNEUMOVIRUS (AMPV)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination